{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:33:17Z","timestamp":1790836397509,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001675","name":"International Brain Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00278268"],"award-info":[{"award-number":["RS-2023-00278268"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.arr.2024.102411","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:56:34Z","timestamp":1720486594000},"page":"102411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Exploring advancements in early detection of Alzheimer's disease with molecular assays and animal models"],"prefix":"10.1016","volume":"100","author":[{"given":"Paalki","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Avinash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Koul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Kumar","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102411_bib1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102411_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-28","article-title":"Development of transgenic rats producing human \u03b2-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically","volume":"9","author":"Agca","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020288","article-title":"Modeling Alzheimer\u2019s Disease in Caenorhabditis elegans","volume":"10","author":"Alvarez","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102411_bib4","first-page":"419","article-title":"Alzheimer Disease","volume":"22","author":"Apostolova","year":"2016","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer\u2019s Disease Clinical Spectrum","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.arr.2024.102411_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030114","article-title":"Biomarkers for Alzheimer\u2019s Disease Early Diagnosis","volume":"10","author":"Aus\u00f3","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.arr.2024.102411_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101409","article-title":"Alzheimer\u2019s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound","volume":"12","author":"Baazaoui","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102411_bib8","first-page":"19","article-title":"A novel Caenorhabditis elegans model of Alzheimer\u2019s Disease","author":"Bajuszova","year":"2023","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102411_bib9","first-page":"5769","article-title":"Emerging Therapeutic Targets in Molecular Neuropharmacology for Alzheimer\u2019s Disease","volume":"37","author":"Bano","year":"2023","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.arr.2024.102411_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66584-8","article-title":"Amyloid precursor protein-b facilitates cell adhesion during early development in zebrafish","volume":"10","author":"Banote","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102411_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102411_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.arr.2024.102411_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ajp.23289","article-title":"Towards developing a rhesus monkey model of early Alzheimer's disease focusing on women's health","volume":"83","author":"Beckman","year":"2021","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.arr.2024.102411_bib14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1582-4934.2009.00781.x","article-title":"The rat as an animal model of Alzheimer's disease","volume":"13","author":"Benedikz","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2024.102411_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-170602","article-title":"Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer\u2019s Disease Pathology and Neuronal Damage","volume":"62","author":"Bettcher","year":"2018","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","article-title":"Tau-imaging in neurodegeneration","volume":"130","author":"Bischof","year":"2017","journal-title":"Methods"},{"key":"10.1016\/j.arr.2024.102411_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","article-title":"Brain arteriolosclerosis","volume":"141","author":"Blevins","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102411_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102411_bib19","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.1074\/jbc.RA118.001848","article-title":"TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function","volume":"293","author":"Cheng","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102411_bib20","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","article-title":"MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"26","author":"Chopra","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102411_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082052","article-title":"Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease","volume":"15","author":"Colavitta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102411_bib22","article-title":"Enhancement of select cognitive domains with rosiglitazone implicates dorsal hippocampus circuitry sensitive to PPAR\u03b3 agonism in an Alzheimer's mouse model","volume":"11","author":"Cortez","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.arr.2024.102411_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.603854","article-title":"Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis","volume":"12","author":"Cui","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","article-title":"Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond","volume":"15","author":"Cuyvers","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib25","article-title":"Presenilins and -Secretase: Structure, Function, and Role in Alzheimer Disease","volume":"2","author":"De Strooper","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2024.102411_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer\u2019s Disease","author":"De-Paula","year":"2012","journal-title":"Protein Aggreg. Fibrillogenesis Cereb. Syst. Amyloid Dis."},{"key":"10.1016\/j.arr.2024.102411_bib27","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","article-title":"Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer\u2019s disease pathogenesis","volume":"76","author":"Dhiman","year":"2019","journal-title":"Cell. Mol. life Sci."},{"key":"10.1016\/j.arr.2024.102411_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-37","article-title":"Modeling Alzheimer\u2019s disease in transgenic rats","volume":"8","author":"Do Carmo","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102411_bib29","first-page":"1","article-title":"Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer\u2019s Disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.arr.2024.102411_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2018.12.041","article-title":"Sitagliptin protects the cognition function of the Alzheimer\u2019s disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings","volume":"696","author":"Dong","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102411_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2018.06.015","article-title":"Identification of nicotianamine synthase genes in Triticum monococcum and their expression under different Fe and Zn concentrations","volume":"672","author":"Du","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.arr.2024.102411_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102411_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0335-x","article-title":"Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer\u2019s disease","volume":"10","author":"Duits","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102411_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-981-32-9358-8_23","article-title":"Tau Prion-Like Propagation: State of the Art and Current Challenges","author":"Dujardin","year":"2019","journal-title":"Tau Biol."},{"key":"10.1016\/j.arr.2024.102411_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2004-6301","article-title":"Rat transgenic models with a phenotype of intracellular A\u03b2 accumulation in hippocampus and cortex","volume":"6","author":"Echeverria","year":"2004","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/nan.12387","article-title":"Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease","volume":"43","author":"Ehrenberg","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2024.102411_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10519-006-9118-z","article-title":"Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration","volume":"37","author":"Eriksen","year":"2006","journal-title":"Behav. Genet."},{"key":"10.1016\/j.arr.2024.102411_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.arr.2024.102411_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/1673-5374.331867","article-title":"Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging","volume":"18","author":"Flores","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102411_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/1570159X19666210524155944","article-title":"Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease","volume":"20","author":"Freeman","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101907","article-title":"Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity","volume":"198","author":"Gallrein","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102411_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102411_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/iub.1532","article-title":"Epigenomic maintenance through dietary intervention can facilitate DNA repair process to slow down the progress of premature aging","volume":"68","author":"Ghosh","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.arr.2024.102411_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2174\/1570159X18666200429011823","article-title":"Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease","volume":"18","author":"Ghosh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s42823-022-00397-9","article-title":"Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer\u2019s disease","volume":"32","author":"Ghosh","year":"2022","journal-title":"Carbon Lett."},{"key":"10.1016\/j.arr.2024.102411_bib46","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(23)01084-X","article-title":"Balancing potential benefits and ethical considerations of gene editing","volume":"401","author":"Ghosh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102411_bib47","first-page":"1","article-title":"From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in maintaining cellular homeostasis and potential therapeutic implications","author":"Ghosh","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2024.102411_bib48","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1523\/JNEUROSCI.0283-04.2004","article-title":"Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in TransgenicDrosophila","volume":"24","author":"Greeve","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102411_bib50","first-page":"18","article-title":"Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging","volume":"3","author":"Gupta","year":"2015","journal-title":"Alzheimer'S. Dement.: Diagn., Assess. Dis. Monit."},{"key":"10.1016\/j.arr.2024.102411_bib51","first-page":"1265","article-title":"Impaired APP activity and altered tau splicing in embryonic stem cell-derived astrocytes derived from the APPsw transgenic minipig","volume":"8","author":"Hall","year":"2015","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.arr.2024.102411_bib52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102411_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00838","article-title":"The Use of Pigs as a Translational Model for Studying Neurodegenerative Diseases","volume":"10","author":"Hoffe","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.arr.2024.102411_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5209-10.2011","article-title":"PKC \u03b5 Activation Prevents Synaptic Loss, A\u03b2 Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice","volume":"31","author":"Hongpaisan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinbiochem.2019.04.002","article-title":"Search for biomarkers of Alzheimer\u2018s disease: Recent insights, current challenges and future prospects","volume":"72","author":"Hrube\u0161ov\u00e1","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2024.102411_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative Memory Deficits, A\u03b2 Elevation, and Amyloid Plaques in Transgenic Mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102411_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102411_bib58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102411_bib59","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3233\/JAD-160408","article-title":"Expression of the Alzheimer\u2019s Disease Mutations A\u03b2PP695sw and PSEN1M146I in Double-Transgenic G\u00f6ttingen Minipigs","volume":"53","author":"Jakobsen","year":"2016","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib60","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","article-title":"Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid","volume":"15","author":"Jia","year":"2019","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102411_bib61","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-150036","article-title":"Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer\u2019s Disease","volume":"46","author":"Jongbloed","year":"2015","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2009.07.041","article-title":"Amyloid precursor protein is required for convergent-extension movements during Zebrafish development","volume":"335","author":"Joshi","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.arr.2024.102411_bib63","first-page":"101","article-title":"Using the mouse to model human disease: increasing validity and reproducibility","author":"Justice","year":"2016","journal-title":"Co. Biol. Ltd"},{"key":"10.1016\/j.arr.2024.102411_bib64","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","article-title":"NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy","volume":"25","author":"Kabir","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.arr.2024.102411_bib65","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/biom9110734","article-title":"Elevated Plasma microRNA-206 Levels Predict Cognitive Decline and Progression to Dementia from Mild Cognitive Impairment","volume":"9","author":"Kenny","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102411_bib66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1533317513520214","article-title":"Detection of Amyloid \u03b2 Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer\u2019s Disease","volume":"30","author":"Kerbage","year":"2014","journal-title":"Am. J. Alzheimer'S. Dis. Other Dement."},{"key":"10.1016\/j.arr.2024.102411_bib67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0031-9384(02)00639-X","article-title":"Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months","volume":"75","author":"King","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2024.102411_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2009.04.005","article-title":"Protection against A\u03b2-mediated rapid disruption of synaptic plasticity and memory by memantine","volume":"32","author":"Klyubin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102411_bib69","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11248-009-9245-4","article-title":"Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer\u2019s disease-causing dominant mutation APPsw","volume":"18","author":"Kragh","year":"2009","journal-title":"Transgenic Res."},{"key":"10.1016\/j.arr.2024.102411_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2016.05.014","article-title":"CSF A\u03b21\u201342 \u2013 an excellent but complicated Alzheimer's biomarker \u2013 a route to standardisation","volume":"467","author":"Kuhlmann","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2024.102411_bib71","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102411_bib72","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102411_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102182","article-title":"MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease","volume":"48","author":"Kumar","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2024.102411_bib74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in Alzheimer disease","volume":"79","author":"La Morgia","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib75","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031781","article-title":"Molecular biomarkers of Alzheimer's disease: progress and prospects","volume":"11","author":"Lashley","year":"2018","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.arr.2024.102411_bib76","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160748","article-title":"A Method for Diagnosing Alzheimer\u2019s Disease Based on Salivary Amyloid-\u03b2 Protein 42 Levels","volume":"55","author":"Lee","year":"2016","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib77","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer\u2019s disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102411_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102411_bib79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ame2.12092","article-title":"Current state of research on non-human primate models of Alzheimer\u2019s disease","volume":"2","author":"Li","year":"2019","journal-title":"Anim. Models Exp. Med."},{"key":"10.1016\/j.arr.2024.102411_bib80","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1021\/acschemneuro.0c00574","article-title":"Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer\u2019s Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP\/PS1 Transgenic Mice","volume":"11","author":"Li","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib81","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1002\/jcb.27023","article-title":"Pterostilbene inhibits amyloid-\u03b2-induced neuroinflammation in a microglia cell line by inactivating the NLRP3\/caspase-1 inflammasome pathway","volume":"119","author":"Li","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.arr.2024.102411_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-015-0250-y","article-title":"Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models","volume":"3","author":"Liao","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102411_bib83","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.029","article-title":"Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion","volume":"28","author":"Liu","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib84","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.353484","article-title":"Targeting neuroinflammation in Alzheimer\u2019s disease: from mechanisms to clinical applications","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102411_bib85","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102411_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2012.00327","article-title":"Studying micro RNA Function and Dysfunction in Alzheimer\u2019s Disease","volume":"3","author":"Lukiw","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.arr.2024.102411_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00778","article-title":"Targeting Synaptic Plasticity in Experimental Models of Alzheimer\u2019s Disease","volume":"10","author":"Mango","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer\u2019s disease mouse model","volume":"24","author":"Martin","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102411_bib89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","article-title":"Cognitive deficits in single App knock-in mouse models","volume":"135","author":"Masuda","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2024.102411_bib90","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102411_bib91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","article-title":"Animal models of CNS disorders","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313168","article-title":"A Review of the Current Mammalian Models of Alzheimer\u2019s Disease and Challenges That Need to Be Overcome","volume":"22","author":"McKean","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102411_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102335","article-title":"Overlooked cases of mild cognitive impairment: Implications to early Alzheimer\u2019s disease","volume":"98","author":"Mian","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102411_bib94","first-page":"1019","article-title":"SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan","volume":"19","author":"Mishra","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib95","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer\u2019s fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102411_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/CEOR.S146788","article-title":"Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer\u2019s disease in Japan","volume":"10","author":"Montgomery","year":"2017","journal-title":"Clinicoecon Outcomes Res."},{"key":"10.1016\/j.arr.2024.102411_bib97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/cn500242z","article-title":"Hyperspectral Imaging Signatures Detect Amyloidopathy in Alzheimer\u2019s Mouse Retina Well before Onset of Cognitive Decline","volume":"6","author":"More","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib98","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/FBP.0b013e3283123cad","article-title":"Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats","volume":"19","author":"Mor\u00e8","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib99","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","article-title":"Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse","volume":"172","author":"Morton","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2024.102411_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115549","article-title":"Alzheimer\u2019s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment","volume":"22","author":"Nakai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102411_bib101","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102411_bib102","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","article-title":"Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: metaan\u00e1lisis","volume":"32","author":"Niu","year":"2017","journal-title":"Neurol. \u00eda"},{"key":"10.1016\/j.arr.2024.102411_bib104","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/1516-4446-2019-0735","article-title":"Early diagnosis and treatment of Alzheimer\u2019s disease: new definitions and challenges","volume":"42","author":"Pais","year":"2020","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.arr.2024.102411_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2017.02.012","article-title":"Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease","volume":"54","author":"Perez","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102411_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7050063","article-title":"Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer\u2019s Disease","volume":"7","author":"Pinto","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2024.102411_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101843","article-title":"DDQ anti-aging properties expressed with improved mitophagy in mutant tau HT22 neuronal cells","volume":"75","author":"Pradeepkiran","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2024.102411_bib110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102411_bib111","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102411_bib112","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-35","article-title":"Drosophila melanogaster as a model organism for Alzheimer\u2019s disease","volume":"8","author":"Pr\u00fc\u00dfing","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102411_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80164-w","article-title":"The A\u03b2(1\u201338) peptide is a negative regulator of the A\u03b2(1\u201342) peptide implicated in Alzheimer disease progression","volume":"11","author":"Quartey","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102411_bib114","doi-asserted-by":"crossref","first-page":"23780","DOI":"10.1039\/C8RA03620A","article-title":"Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease","volume":"8","author":"Rajasekhar","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2024.102411_bib115","first-page":"123","article-title":"<p>Alzheimer\u2019s Disease \u2013 Why We Need Early Diagnosis<\/p>.","volume":"Volume 9","author":"Rasmussen","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102411_bib117","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1523\/JNEUROSCI.0862-17.2017","article-title":"Glial Draper Rescues A\u03b2 Toxicity in aDrosophilaModel of Alzheimer's Disease","volume":"37","author":"Ray","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib118","article-title":"Amyloid-\u03b2 and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer\u2019s Disease","author":"Reddy","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2024.102411_bib119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-006-0166-5","article-title":"Effects of Cerebrolysin\u2122 on neurogenesis in an APP transgenic model of Alzheimer\u2019s disease","volume":"113","author":"Rockenstein","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102411_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102291","article-title":"Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems","volume":"97","author":"Roghani","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102411_bib121","first-page":"108","article-title":"Alzheimer's disease biomarkers in animal models: closing the translational gap","volume":"2","author":"Sabbagh","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib122","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-018-1160-y","article-title":"Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer\u2019s disease dementia from normal controls: preliminary findings","volume":"18","author":"Sabbagh","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib123","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3233\/JAD-231181","article-title":"Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer\u2019s Disease","volume":"98","author":"Sachdeva","year":"2024","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102411_bib125","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0424-5","article-title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer\u2019s disease (BLAZE)","volume":"10","author":"Salloway","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102411_bib126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clinbiochem.2019.08.008","article-title":"AD biomarker discovery in CSF and in alternative matrices","volume":"72","author":"Sancesario","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2024.102411_bib127","first-page":"264259","article-title":"2020.A non-human primate model of familial Alzheimer\u2019s disease","volume":"2020","author":"Sato","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.arr.2024.102411_bib128","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102411_bib129","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2024.102411_bib130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41418-019-0409-3","article-title":"Impaired adult neurogenesis is an early event in Alzheimer\u2019s disease neurodegeneration, mediated by intracellular A\u03b2 oligomers","volume":"27","author":"Scopa","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102411_bib131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-191081","article-title":"Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-\u03b2 Precursor Protein","volume":"75","author":"Seita","year":"2020","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib132","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2017.09.017","article-title":"Lower vertebrate and invertebrate models of Alzheimer's disease \u2013 A review","volume":"815","author":"Sharma","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102411_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102211","article-title":"Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways","volume":"96","author":"Sinha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102411_bib134","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0380-x","article-title":"pGluA\u03b2 increases accumulation of A\u03b2 in vivo and exacerbates its toxicity","volume":"4","author":"Sofola-Adesakin","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102411_bib135","doi-asserted-by":"crossref","DOI":"10.1177\/1178646920972657","article-title":"The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer\u2019s Disease","volume":"13","author":"Sorgdrager","year":"2020","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.arr.2024.102411_bib136","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102411_bib137","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2024.102411_bib138","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Tam","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102411_bib139","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib140","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102411_bib141","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s12640-021-00343-z","article-title":"Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer\u2019s Disease","volume":"39","author":"Thawkar","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2024.102411_bib142","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-60761-898-0_16","article-title":"Lesion-Induced Vertebrate Models of Alzheimer Dementia","author":"Toledano","year":"2011","journal-title":"Anim. Models Dement."},{"key":"10.1016\/j.arr.2024.102411_bib143","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer's Disease","volume":"19","author":"Trejo-Lopez","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2024.102411_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/ahg.12554","article-title":"Using Drosophila amyloid toxicity models to study Alzheimer's disease","author":"Tsintzas","year":"2024","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.arr.2024.102411_bib145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-981-13-0529-0_3","article-title":"Alzheimer\u2019s Disease Model System Using Drosophila","author":"Tsuda","year":"2018","journal-title":"Drosoph. Models Hum. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112089","article-title":"Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits","volume":"373","author":"Van Erum","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2024.102411_bib147","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3233\/JAD-231281","article-title":"Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer\u2019s Disease","volume":"98","author":"Vijayan","year":"2024","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib148","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2024.102411_bib149","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-200995","article-title":"Ameliorating Ribosylation-Induced Amyloid-\u03b2 Pathology by Berberine via Inhibiting mTOR\/p70S6K Signaling","volume":"79","author":"Wang","year":"2021","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib150","first-page":"8","article-title":"Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy","author":"Wattmo","year":"2016","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102411_bib151","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ceo.12872","article-title":"Emerging ocular biomarkers of Alzheimer disease","volume":"45","author":"van Wijngaarden","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.arr.2024.102411_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110614","article-title":"Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice","volume":"106","author":"Yan","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.arr.2024.102411_bib153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3177\/jnsv.68.228","article-title":"Berberine Ameliorates Cognitive Disorder via GSK3\u03b2\/PGC-1\u03b1 Signaling in APP\/PS1 Mice","volume":"68","author":"Yang","year":"2022","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.arr.2024.102411_bib154","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib155","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102411_bib156","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102411_bib157","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102411_bib158","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-181038","article-title":"TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis","volume":"68","author":"Zhou","year":"2019","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102411_bib159","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2023.09.015","article-title":"Role and molecular regulatory mechanisms of Hippo signaling pathway in Caenorhabditis elegans and mammalian cell models of Alzheimer\u2019s disease","volume":"134","author":"Zhu","year":"2024","journal-title":"Neurobiol. Aging"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724002290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:13:49Z","timestamp":1726632829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724002290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":159,"alternative-id":["S1568163724002290"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102411","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring advancements in early detection of Alzheimer's disease with molecular assays and animal models","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102411"}}